ASHLEY GLAZA: Open Payments
NPI 1366023681 · FORT GRATIOT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 13 payments from 8 companies in 2025. Trend: 2023 $243 · 2024 $174 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $81 |
| PFIZER INC. | 1 | $39 |
| Astellas Pharma US Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
Products named: PAXLOVID, Veozah, Ozempic, MOUNJARO, REXULTI, Auvelity, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
